U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/Grants and Training/< Back ToFunding Opportunities and Contacts/Clinical Trials Optimization

	
Clinical Trials Optimization
								
																									The NHLBI’s new funding announcements will help lead investigators to more interpretable, timely, and useful results, which in turn will improve public health. The NHLBI offers several funding mechanisms tailored to planning and conducting clinical trials at all phases, including pilot studies.
			
								Program Officers
					
      Traci Heath Mondoro, Ph.D.
				
            Early Phase (0, I) Clinical Trials
      
				
            NHLBI_Blood_Training@nhlbi.nih.gov
      
				
            301-435-0050
              Patricia Noel, Ph.D.
				
            Early Phase Clinical Trials
      
				
            noelp@nhlbi.nih.gov
      
				
            301-435-0202
              Nancy DiFronzo, Ph.D.
				
            HSCT and Adoptive Cell Therapy; GVHD; MDS
      
				
            nancy.difronzo@nih.gov
      
				
            301-435-0065
              Yves Rosenberg, M.D., M.P.H.
				
            Multi/Single-Site Trials, DCVS
      
				
            rosenbey@nhlbi.nih.gov
      
				
            301-435-0550
              Andrei Kindzelski, M.D., Ph.D.
				
            Innovative Late Phase U34/X01 Trials
      
				
            kindzelskial@nhlbi.nih.gov
      
				
            301-435-0050
              Kristin Burns, M.D.
				
            Late Phase Trials, DCVS
      
				
            kristin.burns@nih.gov
      
				
            301-594-6859
              Erin Smith
				
            Innovative Clinical Trials Education and Consultative Resource
      
				
            smithee@nhlbi.nih.gov
      
				
            301-435-0065
              Nahed El Kassar, M.D., Ph.D.
				
            Phase II or Later Single Site Trials
      
				
            nahed.elkassar@nih.gov
      
				
            301-435-0065
	Funding Opportunities
				PAR-22-192
       | Released 
            July 12, 2022
                                                    	
	Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
	

                Expires 
            September 12, 2025
              PAR-22-193
       | Released 
            July 12, 2022
                                                    	
	Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
	

                Expires 
            September 12, 2025
              PAR-22-189
       | Released 
            July 12, 2022
                                                    	
	Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
	

                Expires 
            September 12, 2025
  
					View all active NHLBI funding opportunities
	Related Resources
				
				IND/IDE authorization timing requirement for PAR-18-406 and PAR-18-407
              Clinical Trial Development Continuum
              Optimizing NHLBI's Clinical Trials Enterprise
              Funding Policies and Guidelines
              Glossary and Acronym List for Funding
              FAQs – FOAs for Investigator-Initiated Phase II and Above Multi-site Clinical T...
              FAQs – FOA for Investigator-Initiated Phase II and Above Single-site Clinical T...
              FOA Webinar and Slides - Multi-site (June 2016)
              FAQs Mechanistic Clinical Trials Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs